Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Non-Current Debt (2020 - 2022)

ENDRA Life Sciences has reported Non-Current Debt over the past 2 years, most recently at $28484.0 for Q4 2021.

  • Quarterly Non-Current Debt fell 91.55% to $28484.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $28484.0 through Dec 2021, down 91.55% year-over-year, with the annual reading at $28484.0 for FY2021, 91.55% down from the prior year.
  • Non-Current Debt was $28484.0 for Q4 2021 at ENDRA Life Sciences, down from $581314.0 in the prior quarter.
  • Over five years, Non-Current Debt peaked at $581314.0 in Q3 2021 and troughed at $28484.0 in Q1 2021.